Dopamine D2/D3 receptors in human retinal precursor cells

被引：0
|
作者：
Chu, J
Xu, K
Chu, TC
机构：
[1] Spelman Coll, Atlanta, GA 30314 USA
[2] Morehouse Sch Med, Atlanta, GA 30310 USA
来源：
FASEB JOURNAL | 2003年 / 17卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
下载
收藏
页码：A633 / A633
页数：1
相关论文
共 50 条
  • [31] Pramipexole given repeatedly increases responsiveness of dopamine D2 and D3 receptors
    Maj, J
    Dziedzicka-Wasylewska, M
    Rogóz, Z
    Skuza, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R59 - R59
  • [32] Structural basis for Na+-sensitivity in dopamine D2 and D3 receptors
    Michino, Mayako
    Free, R. Benjamin
    Doyle, Trevor B.
    Sibley, David R.
    Shi, Lei
    CHEMICAL COMMUNICATIONS, 2015, 51 (41) : 8618 - 8621
  • [33] Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors
    Thomas, Trayder
    Fang, Yu
    Yuriev, Elizabeth
    Chalmers, David K.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (02) : 308 - 321
  • [34] In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors
    Tadori, Yoshihiro
    Forbes, Robert A.
    McQuade, Robert D.
    Kikuchi, Tetsuro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 668 (03) : 355 - 365
  • [35] Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors:: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist
    Burstein, ES
    Ma, J
    Wong, S
    Gao, Y
    Pham, E
    Knapp, AE
    Nash, NR
    Olsson, R
    Davis, RE
    Hacksell, U
    Weiner, DM
    Brann, MR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1278 - 1287
  • [36] Regulation of human D1, D2(long), D2(short), D3 and D4 dopamine receptors by amiloride and amiloride analogues
    Hoare, SRJ
    Coldwell, MC
    Armstrong, D
    Strange, PG
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) : 1045 - 1059
  • [37] The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
    Wicke, K
    Garcia-Ladona, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (02) : 85 - 90
  • [38] Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets:: Mediation by D2, not D3, dopamine receptors
    Hill, Michael P.
    Ravenscroft, Paula
    McGuire, Steven G.
    Brotchie, Jonathan M.
    Crossman, Alan R.
    Rochat, Catherine
    Millan, Mark J.
    MOVEMENT DISORDERS, 2006, 21 (12) : 2090 - 2095
  • [39] Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia
    Ohara, K
    Nakamura, Y
    Xie, DW
    Ishigaki, T
    Deng, ZL
    Tani, K
    Zhang, HY
    Kondo, N
    Liu, JC
    Miyasato, K
    Ohara, K
    BIOLOGICAL PSYCHIATRY, 1996, 40 (12) : 1209 - 1217
  • [40] Dazzled by the dominions of dopamine: clinical roles of D3, D2, and D1 receptors
    Stahl, Stephen M.
    CNS SPECTRUMS, 2017, 22 (04) : 305 - 311
12345